The "Center for Art Law Report on Anti-Money Laundering and Art" [1]is an enlightening and comprehensive guide that explores the practices of Anti-Money Laundering (AML) in the art sector across ...
Japan’s Daiichi Sankyo is looking at a reduced review time for its acute myeloid leukaemia (AML) drug quizartinib in Europe, the top prospect in its new oncology pipeline. The European Medicines ...